Navigation Links
Navigate Global Health to Provide Medical Travel Services to Acibadem Healthcare Group Hospitals in Turkey
Date:4/27/2009

Navigate Global Health, a provider of medical travel services has expanded its network of internationally recognized Joint Commission International, JCI, accredited hospitals to the Acibadem Healthcare Group. This partnership will combine Navigate's expertise in medical travel with Acibadem's globally recognized medical care. Together Navigate and Acibadem will provide the international medical traveler access to one of worlds highest quality healthcare organizations.

Williston, VT (PRWEB) April 27, 2009 -- Navigate Global Health, a provider of global medical travel for both the individual medical traveler and corporate benefits clients has expanded its network to include the Acibadem Healthcare Group based in Istanbul Turkey.

Navigate Global Health is pleased to announce that it has entered into a partnership with Acibadem Healthcare Group. Acibadem is a Joint Commission International, JCI, accredited and Harvard Medical International, HMI, affiliated healthcare group. The addition of Acibadem to the Navigate network will provide medical travelers from North America access to medical, dental and cosmetic procedures of the highest caliber. The affordability of this high quality medical care will surprise most North Americans accustomed to the high cost of healthcare.

Melis Zorluolu of Acibadem Healthcare Groups International Patient Center is keen to point out "Acibadem is recognized first for its quality care. It is an added benefit that Acibadem is able to provide such high quality care at an affordable price." Zorluolu continues "Acib
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

2

GOOD

Page: 1 2 3

Related medicine news :

1. Retailers, Buyers to Learn how to Navigate Probiotic Marketplace at Natural Products Expo West 2009
2. Blind Man Navigates Obstacle Course Without Error
3. Expanded Seconds-Count.org Helps Physicians Navigate Spectrum of Cardiovascular Disease Treatment Options
4. Mariner Zac Sunderland Sets Sail on Quest to Become the Youngest to Circumnavigate the Globe Solo
5. New Web Site Helps Patients Navigate Heart Disease Treatment Options
6. ACS Launches Product to Help Employers Navigate Health Choices For Employees Entering Retirement Years
7. Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca
8. Global AIDS Alliance Fund Welcomes Eric Goosby to Office of The Global Aids Coordinator
9. AMD Global Telemedicine Inc. to Unveil New Solutions at ATA 2009 Conference in Las Vegas
10. GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care
11. Global health experts release new guidance on malaria elimination
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Navigate Global Health to Provide Medical Travel Services to Acibadem Healthcare Group Hospitals in Turkey
Navigate Global Health to Provide Medical Travel Services to Acibadem Healthcare Group Hospitals in Turkey
Breaking Medicine News(10 mins):Health News:You Never Get a Second Chance to Make a First Impression: High-Definition for the Web 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 3Health News:Lung Cancer Alliance Praises Growing National Coalition 2Health News:Lung Cancer Alliance Praises Growing National Coalition 3Health News:Book Offers Help for Parents Struggling with Difficult Teens During the Upcoming Holidays 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4
Breaking Medicine Technology:Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 1New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 2New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 3Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange 28TM 29 61028 1Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange 28TM 29 61028 2PIA Says Inclusion of Agents in House Healthcare Bill is Positive But Concerns Remain 61024 1PIA Says Inclusion of Agents in House Healthcare Bill is Positive But Concerns Remain 61024 2PIA Says Inclusion of Agents in House Healthcare Bill is Positive But Concerns Remain 61024 3
Other Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5